TACE: Therapy of the HCC before liver transplantation - Experiences;TACE: Therapie des HCC vor lebertransplantation - Erfahrungen

RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren

Volumn 177, Issue 5, 2005, Pages 681-690

  Herber, Sascha ^a,d   Schneider, J ^a   Brecher, B ^a   Hohler T ^c   Thelen, M ^a   Otto, G ^b   Pitton, M B ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b Gallenwegen und Pankreas   (Germany)

^c Klinik und Poliklinik für Innere Medizin 1   (Germany)

^d JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Chemoembolization; HCC; Liver transplantation; TACE; Tumor recurrence

Indexed keywords

IODINATED POPPYSEED OIL; MITOMYCIN C; ANTINEOPLASTIC AGENT; MITOMYCIN;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER FUNCTION; LIVER TRANSPLANTATION; MALE; PATIENT SELECTION; PORTAL VEIN; PRIORITY JOURNAL; TIME SERIES ANALYSIS; TRANSARTERIAL CHEMOEMBOLIZATION; TREATMENT OUTCOME; TUMOR VOLUME; VASCULAR PATENCY; CLINICAL TRIAL; HOSPITALIZATION; LIVER TUMOR; METHODOLOGY; MIDDLE AGED; PREOPERATIVE CARE; PROGNOSIS; RADIOGRAPHY; RISK ASSESSMENT; RISK FACTOR;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; IODIZED OIL; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MITOMYCIN; PREOPERATIVE CARE; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 20844457662     PISSN: 14389029     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-858100     Document Type: Article

References (38)

1. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology 2003; 37: 429-442
2. Frilling A, Malgo M, Broelsch C. Current status of liver transplantation for treatment of hepatocellular carcinoma. Digestive Diseases 2001; 19: 333-337
3. Poon RTP, Fan ST, Wong J. Risk factors, prevention and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 2000; 232: 10-24
4. Bismuth H, Majno P. Hepatobiliary surgery. J Hepatol 2000; 32: 208-224
5. Paye F, Jagot P, Vilgrain V et al. Preoperative chemoembolization of hepatocellular carcinoma: a comparative study. Arch Surg 1998; 133: 767-772
6. Mazzaferro V, Regalia E, Doci R et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-699
7. Stippel DL, Kasper HU, Schleimer K et al. Underestimation of nodules while staging hepatocellular carcinoma prior to neoadjuvant treatment on waiting list for transplantation. Transplant Proc 2003; 35: 1423-1424
8. Llovet JM, Real MI, Montana X et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002; 359: 1734-1739
9. Tacke J. Perkutane Radiofrequenzablation - Klinische Indikation und Resultate. Fortschr Röntgenstr 2003; 175: 156-168
10. Lo CM, Ngan H, Tso WK et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002; 35: 1164-1171
11. Bruix J, Llovet JM, Castells A et al. Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution. Hepatology 1998; 27: 1578-1583
12. Vogl TJ, Schroeder H, Trapp M et al. Multisequentielle arterielle Chemoembolisation fortgeschrittener hepatozellulärer Karzinome: Computertomographische Verlaufsparameter zur Beurteilung des Ansprechensauf die Therapie. Fortschr Röntgenstr 2000; 172: 43-50
13. Jaeger HJ, Mehring UM, Castaneda F et al. Sequential transarterial chemoembolization for unresectable advanced hepatocellular carcinoma. Cardiovasc Intervent Radiol 1996; 19: 388-396 (Review)
14. Veltri A, Grosso M, Martina MC et al. Effect of preoperative radiological treatment of hepatocellular carcinoma before liver transplantation: a retrospective study. Cardiovasc Intervent Radiol 1998; 21: 393-398
15. Spreafico C, Marchiano A, Regalia E et al. Chemoembolization of hepatocellular carcinoma in patients who undergo liver transplantation. Radiology 1994; 192: 687-690
16. Hashimoto T, Nakamura H, Hori S et al. Hepatocellular carcinoma: efficacy of transcatheter oily chemoembolization in relation to macroscopic and microscopic patterns of tumor growth among 100 patients with partial hepatectomy. Cardiovasc Intervent Radiol 1995; 18: 82-86
17. Molmenti EP, Klintmalm GB. Hepatocellular cancer in liver transplantation. J Hepatobiliary Pancreat Surg 2001; 8: 427-434
18. Gonzalez-Uriarte J, Valdivieso A, Gastaca M et al. Liver transplantation for hepatocellular carcinoma in cirrhotic patients. Transplantation Proceedings 2003; 35: 1827-1829
19. Fernandez JA, Robles R, Marin C et al. Can we expand the indications for liver transplantation among hepatocellular carcinoma patients with increased tumor size? Transplant Proc 2003; 35: 1818-1820
20. Llovet JM, Burroughs A, Bruix J. Hepatocelluar cracinoma. Lancet 2003; 6: 1907-1917
21. Valls C, Cos M, Figueras J et al. Pretransplantation diagnosis and staging of hepatocellular carcinoma in patients with cirrhosis: vlaue of dual-phase helical ct. AJR 2004; 182: 1011-1017
22. Majno PE, Adam R, Bismuth H et al. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg 1997; 226: 688-701
23. De Carlis L, Giacomoni A, Lauterio A et al. Liver transplantation for hepatocellular cancer: should the current indication criteria be changed? Transpl Int 2003; 16: 115-122
24. Ramsey DE, Geschwind JF. Chemoembolization of hepatocellular carcinoma - what to tell the skeptics: review and meta-analysis. Tech Vasc Interv Radiol 2002; 5: 122-126
25. Huang YS, Chiang JH, Wu JC et al. Risk of hepatic failure after transcatheter arterial chemoembolization for hepatocellular carcinoma: predictive value of the monoethylglycinexylidide test. Am J Gastroenterol 2002; 97: 1223-1227
26. Pelletier G, Ducreux M, Gay F et al. Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial. Groupe CHC. J Hepatol 1998; 29: 129-134
27. Huppert PE, Lauchart W, Duda S et al. Chemoembolisation des hepatozellulären Karzinoms: Welche Faktoren bestimmen Therapieansprechen und Überleben? Fortschr Röntgenstr 2004; 176: 375-385
28. Yuen MF, Cheng CC, Lauder IJ et al. Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience. Hepatology 2000; 31: 330-335
29. Yao F, Bass N, Nikolai B et al. A follow up analysis of the pattern and predictors of drop-out from the waiting list for liver transplantation in patients with hepatocellular carcinoma: implications for the current allocation policy. Liver Transplant 2003; 9: 684-692
30. Harada T, Matsuo K, Inoue T et al. Related Articles, Is preoperative hepatic arterial chemoembolization safe and effective for hepatocellular carcinoma? Ann Surg 1996; 224: 4-9
31. Sugo H, Futagawa S, Beppu T et al. Role of preoperative transcatheter arterial chemoembolization for resectable hepatocellular carcinoma: relation between postoperative course and the pattern of tumor recurrence. World J Surg 2003; 27: 1295-1299
32. Graziadei IW, Sandmueller H, Waldenberger P et al. Chemoembolization followed by liver transplantation für hepatocellular carcinoma impeds tumor progression while on the waiting list and leads to excellent outcome. Liver Transpl 2003; 9: 557-563
33. Margarit C, Charco R, Hidalgo E et al. Liver transplantation for malignant diseases: selection and pattern of reccurence. World J Surg 2002; 26: 257-263
34. Lopez RR, Pan S, Pharm D et al. Comparison of transarterial chemoembolization in patients with unresectable, diffuse vs focal hepatocellular carcinoma. Arch Surg 2002; 137: 653-658
35. Marsh J, Dvorchik I, Iwatsuki S. Liver transplantation in the treatment of hepatocellular carcinoma. J Hep Bil Pancr Surg 1998; 5: 2
36. Roayaie S, Schwartz J, Sung M et al. Recurrence of Hepatocellular carcinoma after liver transplant: patterns and prognosis. Liver Transplant 2004; 10: 534-540
37. Cheng SJ, Freeman RB Jr, Wong JB. Predicting the probability of progression-free survival in patients with small hepatocellular carcinoma. Liver Transpl 2002; 8: 329-330
38. Barbara L, Benzi G, Gaiani S et al. Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor groth rate and patient survival. Hepatology 1992; 16: 132-137